Valeant Pharmaceuticals v. Actavis Laboratories Fl., Inc
Valeant Pharmaceuticals v. Actavis Laboratories Fl., Inc
Opinion
Case: 20-1201 Document: 54 Page: 1 Filed: 12/18/2020
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
VALEANT PHARMACEUTICALS INTERNATIONAL, SALIX PHARMACEUTICALS LTD., COSMO TECHNOLOGIES LIMITED, Plaintiffs-Appellants
v.
ACTAVIS LABORATORIES FL., INC., ACTAVIS PHARMA, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., Defendants-Appellees ______________________
2020-1201 ______________________
Appeal from the United States District Court for the District of Delaware in No. 1:18-cv-01288-LPS, Chief Judge Leonard P. Stark. ______________________
JUDGMENT ______________________
THOMAS P. STEINDLER, McDermott, Will & Emery LLP, Washington, DC, argued for all plaintiffs-appellants. Plaintiffs-appellants Valeant Pharmaceuticals Interna- tional, Salix Pharmaceuticals Ltd. also represented by CHRISTOPHER MICHAEL BRUNO, PAUL MICHAEL Case: 20-1201 Document: 54 Page: 2 Filed: 12/18/2020
SCHOENHARD.
GARY N. FRISCHLING, Milbank LLP, Los Angeles, CA, for plaintiff-appellant Cosmo Technologies Limited. Also represented by YITE JOHN LU.
WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for defendants-appellees. Also represented by JOHN T. BENNETT, GERARD JUSTIN CEDRONE, SAMUEL SHERRY, Boston, MA; ELIZABETH HOLLAND, New York, NY. ______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (NEWMAN, DYK, and REYNA, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
December 18, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Reference
- Status
- Unpublished